Fig. 4From: Cost utility of a pharmacist-led minor ailment service compared with usual pharmacist careCost effectiveness acceptability curve showing the probability of MAS being cost-effective at different willingness-to-pay thresholds. AUD Australian dollars, ICER incremental cost effectiveness ratio, QALY quality adjusted life yearBack to article page